Inovio Pharmaceuticals, Inc.
INO
Revenue
100.76k
▲100.76k∞%
3 Months ChangeAssets
133.80M
▲4.68M▲3.63%
3 Months ChangeLiabilities
37.06M
▲2.39M▲6.88%
3 Months ChangeFree Cash Flow
-28.80M
▲8.17M▲22.09%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 8-K
ID: 0001193125-24-199331
2024-08-08
Form 8-K
ID: 0001193125-24-197065
2024-08-08
Form 10-Q
ID: 0001055726-24-000046
2024-05-28
Form 8-K
ID: 0001193125-24-148076
2024-05-13
Form 8-K
ID: 0001193125-24-137228
2024-05-13
Form 10-Q
ID: 0001055726-24-000020
2024-04-17
Form 8-K
ID: 0001193125-24-099067
2024-01-25
Form 8-K
ID: 0001193125-24-015380
2024-01-12
Form 8-K
ID: 0001193125-24-007674
2023-11-09
Form 8-K
ID: 0001193125-23-274515